General Information
Revision date
2004-07-29
Product name
Erythromycin
Product Synonyms
Erythromycin Ointment
Chemical name
Erythromycin
CAS No.
114-07-8
Emergency telephone
Eli Lilly and Company
Icons in SDS
Company Information
company name
Eli Lilly and Company
Section 2
SECTION 2: Hazards identification
Appearance: Translucent homogeneous ointment Physical State: Solid Odor: Odorless Emergency Overview Emergency Overview Effective Date: 27-Oct-1999 Lilly Laboratory Labeling Codes: Health 1 Fire 1 Reactivity 0 Primary Physical and Health Hazards: Suspect Allergen. Caution Statement: Erythromycin Ointment may cause allergic reactions.
Principle Routes of Exposure
Skin contact Effects of Overexposure: Erythromycin Ointment is intended for human application under guidance of a physician. Ointments are not considered hazardous under normal handling conditions. Based on clinical data with erythromycin estolate, allergic reactions might be expected to occur in rare instances.
Medical Conditions Generally Aggravated by Exposure
Erythromycin - Hypersensitivity to erythromycin or macrolide antibiotics. Carcinogenicity: Erythromycin - Not listed by IARC, NTP, ACGIH, or OSHA. Two-year dietary studies with erythromycin stearate demonstrated no evidence of carcinogenicity in rats or mice. Iron oxide - IARC Group 3 (not classifiable as to human carcinogenicity). ACGIH A4 (not classifiable as a human carcinogen). Not listed by NTP or OSHA.
